HK1202881A1 - Process for enriching iga iga - Google Patents

Process for enriching iga iga

Info

Publication number
HK1202881A1
HK1202881A1 HK15103456.4A HK15103456A HK1202881A1 HK 1202881 A1 HK1202881 A1 HK 1202881A1 HK 15103456 A HK15103456 A HK 15103456A HK 1202881 A1 HK1202881 A1 HK 1202881A1
Authority
HK
Hong Kong
Prior art keywords
iga
enriching
enriching iga
iga iga
Prior art date
Application number
HK15103456.4A
Other languages
English (en)
Chinese (zh)
Inventor
Menyawi Ibrahim El
Marius Loetscher
Doreen Siegemund
Original Assignee
Csl Behring Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csl Behring Ag filed Critical Csl Behring Ag
Publication of HK1202881A1 publication Critical patent/HK1202881A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
HK15103456.4A 2012-03-09 2015-04-08 Process for enriching iga iga HK1202881A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12158927.9A EP2636681A1 (fr) 2012-03-09 2012-03-09 Procédé d' enrichissement d'IgA
PCT/EP2013/054698 WO2013132053A1 (fr) 2012-03-09 2013-03-08 Procédé pour enrichir la glomérulonéphrite à dépôts mésangiaux d'iga

Publications (1)

Publication Number Publication Date
HK1202881A1 true HK1202881A1 (en) 2015-10-09

Family

ID=47843296

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15103456.4A HK1202881A1 (en) 2012-03-09 2015-04-08 Process for enriching iga iga

Country Status (10)

Country Link
US (1) US9828418B2 (fr)
EP (2) EP2636681A1 (fr)
JP (1) JP6259777B2 (fr)
KR (1) KR102079487B1 (fr)
CN (1) CN104245728B (fr)
AU (1) AU2013201388B2 (fr)
DK (1) DK2822965T3 (fr)
ES (1) ES2919861T3 (fr)
HK (1) HK1202881A1 (fr)
WO (1) WO2013132053A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104254542A (zh) 2012-03-09 2014-12-31 瑞士杰特贝林生物制品有限公司 包含分泌-样免疫球蛋白的组合物
EP2636684A1 (fr) * 2012-03-09 2013-09-11 CSL Behring AG Prévention des infections
DK3016976T3 (da) * 2013-07-01 2020-12-07 Csl Behring Ag Proces
GB201413227D0 (en) 2014-07-25 2014-09-10 Bioproducts Lab Ltd Process
DE202014105749U1 (de) * 2014-11-27 2015-01-09 iCradle GmbH Daumenschalter zur Befestigung an einem Fahrradlenker und über einen derartigen Daumenschalter bedienbares Steuersystem für ein Fahrrad
CN108779166A (zh) * 2015-10-21 2018-11-09 科博锐恩生物制品有限责任公司 从血浆纯化蛋白质的方法
WO2018115048A1 (fr) 2016-12-20 2018-06-28 Csl Behring Ag Procédés pour agir sur des infections par salmonella
MX2020003201A (es) 2017-09-21 2020-08-13 Umc Utrecht Holding Bv Anticuerpo anti-gd2 para el tratamiento del neuroblastoma.
US11312746B2 (en) * 2018-05-17 2022-04-26 Csl Behring Ag Method and system of protein extraction
CA3119238A1 (fr) 2018-11-30 2020-06-04 Csl Behring Ag Procedes et compositions pour prevenir ou traiter des exacerbations aigues avec immunoglobuline polyclonale
KR20220004979A (ko) 2019-03-27 2022-01-12 유엠씨 우트레크트 홀딩 비.브이. 조작된 iga 항체 및 사용 방법
CN112574296B (zh) * 2020-12-30 2023-05-19 中国医学科学院输血研究所 一种模拟IVIg的多人份混合人血浆IgG样品的分离纯化方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5500345A (en) * 1989-04-25 1996-03-19 Iatron Laboratories, Inc. Hybridomas producing monoclonal antibodies specific for C-reactive protein and methods for detection of C-reactive protein
DE3927111C3 (de) 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
US5258177A (en) * 1991-12-10 1993-11-02 Alpha Therapeutic Corporation IgA preparation and process of making the same
FR2706466B1 (fr) 1993-06-14 1995-08-25 Aetsrn Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
EP0724602A4 (fr) 1993-07-30 1998-12-23 Oravax Inc ANTICORPS IgA MONOCLONAL DIRIGE CONTRE LE VIRUS RESPIRATOIRE SYNCYTIAL
DE19600939C1 (de) * 1996-01-12 1997-08-28 Immuno Ag Verfahren zur Trennung von IgG und IgA
EP0839915A1 (fr) 1996-11-01 1998-05-06 Institut Suisse De Recherches Experimentales Sur Le Cancer Isrec Immunoglobuline A sécrétoire comme système d'administration de vaccins mucosales
AU8063798A (en) 1997-06-19 1999-01-04 Regents Of The University Of California, The Secretory immunoglobulin produced by single cells and methods for making and using same
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
US20020114802A1 (en) 1998-02-10 2002-08-22 Tjellstrom Bo Arthur Einar Oral immunoglobulin treatment for inflammatory bowel disease
SK288128B6 (sk) 1998-06-09 2013-10-02 Csl Behring Ag Process for purifying immunoglobulin G (IgG), liquid immunoglobulin product and use thereof for the preparation of a medicament
JP2000103800A (ja) * 1998-09-29 2000-04-11 Yoshitomi Pharmaceut Ind Ltd 免疫グロブリンａの精製方法
AUPP806999A0 (en) * 1999-01-08 1999-02-04 Csl Limited Process for purifying immunoglobulins
EP1068871A1 (fr) 1999-07-07 2001-01-17 Jean-Paul Perraudin Nouvelles méthodes et médicament pour le traitement des infections émanant d'un biofilm microbiel
US7749721B2 (en) 1999-12-13 2010-07-06 Universidad Nacional Autónoma de México Immuno enzymatic quantification method for cholesterol ester transferring protein (CETP)
CA2437814C (fr) 2001-02-12 2008-05-13 Medarex, Inc. Anticorps monoclonaux humains de l'alphabloquant fc (cd89)
US6932967B2 (en) 2001-03-22 2005-08-23 Michael R. Simon Human medical treatment by aerosol inhalation of immunoglobulin A
FR2824568B1 (fr) * 2001-05-11 2004-04-09 Lab Francais Du Fractionnement Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique
US20060165675A1 (en) 2002-08-02 2006-07-27 Richman-Eisenstat Janice Beth Modulation of mesenchymal cells via iga-receptors
BRPI0406605B8 (pt) 2003-11-13 2021-05-25 Hanmi Holdings Co Ltd conjugado de proteína, método para a preparação do mesmo e composição farmacêutica para intensificar a duração e estabilidade in vivo de um polipeptídeo fisiologicamente ativo
US8709413B2 (en) 2006-12-13 2014-04-29 Michael R. Simon Treatment of celiac disease with IgA
US8313730B2 (en) 2006-12-13 2012-11-20 Michael R. Simon Treatment of celiac disease with IgA
US8119104B2 (en) 2006-12-13 2012-02-21 Michael R. Simon Treatment of celiac disease with IgA
US8021645B2 (en) 2006-12-13 2011-09-20 Simon Michael R Synthesis of human secretory IgA and IgM and the formation of a medicament therefrom
US7794721B2 (en) 2006-12-13 2010-09-14 Simon Michael R Synthesis of human secretory IgM and the treatment of clostridium difficile associated diseases herewith
US20080145420A1 (en) 2006-12-13 2008-06-19 Simon Michael R HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES
US7597891B2 (en) 2006-12-13 2009-10-06 Simon Michael R Synthesis of human secretory IgA for the treatment of Clostridium difficile associated diseases
EP2244735A4 (fr) 2007-10-02 2011-02-23 Avaxia Biologics Inc Thérapie aux anticorps pour une utilisation dans le tube digestif
RU2010151414A (ru) 2008-05-15 2012-06-20 В.Хэлт Л.П. (Bs) Способ получения фракций молока, обогащенных секреторными иммуноглобулинами
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
EP2465536A1 (fr) 2010-12-14 2012-06-20 CSL Behring AG Activation CD89 dans une thérapie
WO2013122834A1 (fr) * 2012-02-14 2013-08-22 Bio-Rad Laboratories, Inc. Diminution d'excursions de ph dans la chromatographie échangeuse d'ions
EP2636684A1 (fr) 2012-03-09 2013-09-11 CSL Behring AG Prévention des infections
EP2636683A1 (fr) 2012-03-09 2013-09-11 CSL Behring AG Traitement de la mucositis avec de l' immunoglobulin
CN104254542A (zh) 2012-03-09 2014-12-31 瑞士杰特贝林生物制品有限公司 包含分泌-样免疫球蛋白的组合物
US9334319B2 (en) * 2012-04-20 2016-05-10 Abbvie Inc. Low acidic species compositions

Also Published As

Publication number Publication date
WO2013132053A1 (fr) 2013-09-12
CN104245728B (zh) 2017-11-28
AU2013201388B2 (en) 2015-09-03
EP2822965A1 (fr) 2015-01-14
KR20140136028A (ko) 2014-11-27
CN104245728A (zh) 2014-12-24
EP2636681A1 (fr) 2013-09-11
ES2919861T3 (es) 2022-07-28
AU2013201388A1 (en) 2013-09-26
DK2822965T3 (da) 2022-07-11
KR102079487B1 (ko) 2020-02-21
JP2015509523A (ja) 2015-03-30
US9828418B2 (en) 2017-11-28
JP6259777B2 (ja) 2018-01-10
EP2822965B1 (fr) 2022-05-11
US20150005476A1 (en) 2015-01-01

Similar Documents

Publication Publication Date Title
IL235826A (en) Diazaspirocycloalkanes and thenaspirocycloalkanes and their preparation
ZA201500603B (en) Process
HK1202881A1 (en) Process for enriching iga iga
GB201216921D0 (en) Process
ZA201405746B (en) Rafamycin analogs and methods for making same
GB201207997D0 (en) Process
SG11201500381TA (en) Process
GB201214326D0 (en) Process
EP2837619A4 (fr) Procédé de production de beta -alcoxypropionamide
IL236450A (en) Process for making 5-fluoro-h1-pyrazoles
PL399418A1 (pl) Sposób wytwarzania 4-metoksydihydrochalkonu
EP2852660A4 (fr) Procédé
EP2824130A4 (fr) Procédé de production de polydialkylsilane
ZA201502344B (en) Process
GB201219224D0 (en) Process
GB201318062D0 (en) Process
EP2883960A4 (fr) Procédé de production d'un cristal de -glutamyl-valyl-glycine
SG11201501567QA (en) Method for producing 7-octenal
GB201317561D0 (en) Process
IL234526A (en) METHOD FOR PRODUCING DIETHINE TETRACARBOXIMIDES
GB201316604D0 (en) Process
HUP1200614A2 (en) Process for development catalayzer
HK1206043A1 (en) Process
GB201223071D0 (en) Process
GB201222686D0 (en) Process